Protein biomarkers of nephrotoxicity; A review and findings with cyclosporin A, a signal transduction kinase inhibitor and N-phenylanthranilic acid

Cancer Biomarkers

Volumn 1, Issue 1, 2005, Pages 59-67

  Betton, Graham R ^a   Kenne, Kerstin ^a   Somers, Rebecca ^a   Marr, Andrew ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRANILIC ACID DERIVATIVE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CISPLATIN; CYCLOSPORIN; FENAMIC ACID; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG DESIGN; DRUG EFFECT; HUMAN; KIDNEY; KIDNEY DISEASE; METHODOLOGY; PROTEOMICS; RAT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTHRANILIC ACIDS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CISPLATIN; CYCLOSPORINE; DRUG DESIGN; GENTAMICINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; PROTEOMICS; RATS; SIGNAL TRANSDUCTION;

EID: 36649002717     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2005-1107     Document Type: Review

References (34)

1. H.A. Ragan, Markers of renal function and injury, in: The Clinical Chemistry of Laboratory Animals, W.F. Loeb and F.W. Quimby, eds, Pergamon, New York 1989, pp. 321-343.
2. E. Piperno, Detection of drug induced nephrotoxicity with urinalysis and enzymuria assessment, in: Toxicology of the kidney, J.B. Hook, ed., Raven Press, New York. 1981, pp. 31-55.
3. R.G. Price, Urinary enzymes, nephrotoxicity and renal disease, Toxicology 23 (1982), 99-134.
4. B. Rozell, H.A. Hansson, C. Guthenberg, M.K. Tahir and B. Manervik, Glutathione transferases of classes alpha, mu and pi show selective expression in different regions of rat kidney, Xenobiotica 23 (1993), 835-849.
5. C. Merlet-Benichou, T. Gilbert, J. Vilar, E. Moreau, N. Freund and M. Lelievre-Perorier, Nephron number: variability is the rule, Lab Invest 79 (1999), 515-527.
6. K.M. Madsen and C.C. Tisher, Anatomy of the Kidney, in: Brenner and Rector's The Kidney, B.M. Brenner, ed., 7th Ed, Saunders, Philadelphia, 2004, pp. 1-72.
7. M. Awazu, S. Omori and M. Hida, MAP kinase in renal development Nephrol, Dial.Transplant 17(Suppl9) (2002), 5-7.
8. M.G. Marquez, I. Cabrera, D.J. Serrano and N. Sterin-Speziale, Cell proliferation and morphometric changes in the rat, Anat. Embryol. 205 (2002), 431-440.
9. A. Trevisan, M. Giraldo, M. Borella, S. Bottegal and A. Fabrello, Tubular segment-specific biomarkers of nephrotoxicity in the rat, Toxicol Lett 124 (2001), 113-120.
10. D.S. Baskin and W.L. Stahl, Immunohistochemical localisation of NaATPase in the rat kidney, Histochemistry 73 (1982), 535-548.
11. V. Goransson, P. Hansell, S. Moss, D. Alcorn, C. Johnsson, R. Hallgren and C. Maric, Renomedullary interstitial cells in culture; the osmolality and oxygen tension influence the extracellular amounts of hyaluronan and cellular expression of CD44, Matrix Biol 20 (2001), 129-136.
12. H. VanGoor, W. Coers, M.L.C. Van der Horst, S. Huitema and A.J.H. Suurmeijer, Distribution of cytoskeletal proteins, integrins, leukocyte adhesion molecules and extracellular matrix proteins in plastic embedded human and rat kidneys, Anal Quant Cytol Histol 23 (2001), 345-354.
13. K.N.M. Khan, C.L. Alden, S.E. Gleissner, M.K. Gessford and T.J. Maziasz, Effect of papillotoxic agents on expression of cyclo-oxygenase isoforms in rat kidney, Tox. Pathol. 26 (1998), 137-142.
14. S. Omori, M. Hida, K. Ishikura, S. Kuramochi and M. Awazu. Expression of mitogen activated protein kinase family in rat renal development, Kidney Int 58 (2000), 27-37.
15. P.A. Wojtaszek, L.E. Heasley and T. Berl, In vivo regulation of MAP kinase in Ratus norvegicus renal papilla by water loading and restriction, J Clin Invest 102 (1998), 1874-1881.
16. B. Yang, T.S. Johnson, G.L. Thomas, P.F.Watson, B.Wagner, P.N. Furness and A.M. El Nahas, A shift in Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis, Kidney Int. 62 (2002), 1301-1313.
17. R.P. Amin, A.E. Vickers, F. Sistare et al., Identification of putative gene based markers of renal toxicity, Environ Hlth Perspect 112 (2004), 465-465.
18. W.K. Han, V. Bailly, R. Abichandani, R. Thadhani and J.V. Bonventre, Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury, Kidney Int. 62 (2002), 237-244.
19. T. Ichimura, C.C. Hung, S.A. Yang, J.L. Stevens and J.V. Bonventre, Kidney injury molecule-1: a tissue biomarker for nephrotoxicant-induced renal injury, Am. J. Physiol. Renal Physiol. 286 (2004), F552-F563.
20. S. Hidaki, B. Kranzlin, N. Gretz and R. Witzgall, Urinary clusterin levels in the rat correlate with the severity of tubular damage and may help to differentiate between glomerular and tubular injuries, Cell Tissue Res 310 (2002), 289-296.
21. B.F. Palmer andW.L. Henrich, Toxic nephropathy, in: Brenner and Rector's The Kidney, B.M. Brenner, ed., 7th, Saunders, Philadelphia, 2004, pp. 1625-1658.
22. J. Pedraza-Chaverri, A.E. Gonzalez-Orozco, P.D. Maldonado, D. Barrera, O.N. Medina-Campos and R. Hernandez-Pando, Diallyl disulphide ameliorates gentamicin-induced oxidative stress and nephropathy in rats, Eur. J. Pharmacol. 473 (2003), 71-78.
23. T. Miyaji, A. Kato, H. Yasuda, Y. Fujigaki and A. Hishida, Role of the increase in p21 in cisplatin-induced acute renal failure in rats, J. Amer. Soc. Nephrol. 12 (2001), 900-908.
24. Q. Huang, R.T. Dunn, S. Jayadev, O. DiSorbo, F.D. Pack, S.B. Farr, R.E. Stoll and K.T. Blanchard, Assessment of cisplatin-induced nephrotoxicity by microarray technology, Toxicol. Sci. 63 (2001), 196-207.
25. L.R. Bandara, M.D. Kelly, E.A. Lock and S. Kennedy, A correlation between proteomic evaluation and conventional measurements in the assessment of renal proximal tubular toxicity, Toxicol. Sci. 73 (2003), 195-206.
26. Z. Zhong, G.E. Arteel, H.D. Connor, M. Yin, M.V. Frankenberg, R.E. Stachlewitz, J.A. Raleigh, R.P. Mason and R.G. Thurman, Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine, Amer. J. Physiol. 275 (Renal Physiol 44) (1998), F595-F604.
27. L. Aicher, D. Wahl, A. Arce, O. Grenet and S. Steiner, New insights into cyclosporine A nephrotoxicity by proteome analysis, Electrophoresis 19 (1998), 1998-2003.
28. N. Guerreiro, F. Staedler, O. Grenet, J. Kehren and S.D. Chibout, Toxicogenomics in drug development, Tox. Pathol. 31 (2003), 471-479.
29. M.D. Breyer, C.-M. Hao and Z. Qi, Cyclooxygenase-2 selective inhibitors and the kidney, Curr. Opinion Crit. Care 7 (2001), 393-400.
30. P.H. Bach and N.T.K. Thanh, Papillary necrosis-40 years on, Tox. Pathol. 26 (1998), 73-91.
31. M.D. Aleo, T. Wang, G. Giebisch, M.J. Sanders, A.H. Walsh and A. Lopez-Anaya, Model development and analysis of tenidap-induced proteinuria in the rat, J Pharmacol Exp Ther. 279 (1996), 1318-1326.
32. S. Klahr, The bone morphogenic proteins (BMPs), Their role in renal fibrosis and renal function, J.Nephrol. 16 (2003), 179-185.
33. E.K. Lang, R.J. Macchia, R. Thomas, R. Davis et al., Multiphasic helical CT diagnosis of early medullary and papillary necrosis, J. Endourol. 18 (2004), 49-56.
34. F.W. Falkenberg, H. Hildebrand, L. Lutte, S. Schwengberg, B. Henke et al., Urinary antigens as markers of papillary toxicity. I Identification and characterization of rat kidney papillary antigens with monoclonal antibodies, Arch. Toxicol. 71 (1996), 80-92.